Global Pharmacovigilance Services Market Research Report 2023

Pharmacovigilance Services Market

According to new survey, global Pharmacovigilance Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmacovigilance Services market research.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmacovigilance Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Pharmacovigilance Services Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacovigilance Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Adverse Event Case Management

1.2.3 Aggregate Reporting

1.2.4 Signal Intelligence

1.2.5 Risk Management

1.3 Market by Application

1.3.1 Global Pharmacovigilance Services Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Biotechnology and Pharmaceuticals

1.3.3 Contract Research Organization

1.3.4 Hospital

1.3.5 KPO / BPO

1.3.6 Healthcare Institutions

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pharmacovigilance Services Market Perspective (2018-2029)

2.2 Pharmacovigilance Services Growth Trends by Region

2.2.1 Global Pharmacovigilance Services Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pharmacovigilance Services Historic Market Size by Region (2018-2023)

2.2.3 Pharmacovigilance Services Forecasted Market Size by Region (2024-2029)

2.3 Pharmacovigilance Services Market Dynamics

2.3.1 Pharmacovigilance Services Industry Trends

2.3.2 Pharmacovigilance Services Market Drivers

2.3.3 Pharmacovigilance Services Market Challenges

2.3.4 Pharmacovigilance Services Market Restraints

3.1 Global Top Pharmacovigilance Services Players by Revenue

3.1.1 Global Top Pharmacovigilance Services Players by Revenue (2018-2023)

3.1.2 Global Pharmacovigilance Services Revenue Market Share by Players (2018-2023)

3.2 Global Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmacovigilance Services Revenue

3.4 Global Pharmacovigilance Services Market Concentration Ratio

3.4.1 Global Pharmacovigilance Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Services Revenue in 2022

3.5 Pharmacovigilance Services Key Players Head office and Area Served

3.6 Key Players Pharmacovigilance Services Product Solution and Service

3.7 Date of Enter into Pharmacovigilance Services Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pharmacovigilance Services Historic Market Size by Type (2018-2023)

4.2 Global Pharmacovigilance Services Forecasted Market Size by Type (2024-2029)

5.1 Global Pharmacovigilance Services Historic Market Size by Application (2018-2023)

5.2 Global Pharmacovigilance Services Forecasted Market Size by Application (2024-2029)

6.1 North America Pharmacovigilance Services Market Size (2018-2029)

6.2 North America Pharmacovigilance Services Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pharmacovigilance Services Market Size by Country (2018-2023)

6.4 North America Pharmacovigilance Services Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pharmacovigilance Services Market Size (2018-2029)

7.2 Europe Pharmacovigilance Services Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pharmacovigilance Services Market Size by Country (2018-2023)

7.4 Europe Pharmacovigilance Services Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pharmacovigilance Services Market Size (2018-2029)

8.2 Asia-Pacific Pharmacovigilance Services Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pharmacovigilance Services Market Size by Region (2018-2023)

8.4 Asia-Pacific Pharmacovigilance Services Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pharmacovigilance Services Market Size (2018-2029)

9.2 Latin America Pharmacovigilance Services Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pharmacovigilance Services Market Size by Country (2018-2023)

9.4 Latin America Pharmacovigilance Services Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pharmacovigilance Services Market Size (2018-2029)

10.2 Middle East & Africa Pharmacovigilance Services Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pharmacovigilance Services Market Size by Country (2018-2023)

10.4 Middle East & Africa Pharmacovigilance Services Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 PrimeVigilance

11.1.1 PrimeVigilance Company Detail

11.1.2 PrimeVigilance Business Overview

11.1.3 PrimeVigilance Pharmacovigilance Services Introduction

11.1.4 PrimeVigilance Revenue in Pharmacovigilance Services Business (2018-2023)

11.1.5 PrimeVigilance Recent Development

11.2 Quanticate

11.2.1 Quanticate Company Detail

11.2.2 Quanticate Business Overview

11.2.3 Quanticate Pharmacovigilance Services Introduction

11.2.4 Quanticate Revenue in Pharmacovigilance Services Business (2018-2023)

11.2.5 Quanticate Recent Development

11.3 ProPharma

11.3.1 ProPharma Company Detail

11.3.2 ProPharma Business Overview

11.3.3 ProPharma Pharmacovigilance Services Introduction

11.3.4 ProPharma Revenue in Pharmacovigilance Services Business (2018-2023)

11.3.5 ProPharma Recent Development

11.4 Parexel

11.4.1 Parexel Company Detail

11.4.2 Parexel Business Overview

11.4.3 Parexel Pharmacovigilance Services Introduction

11.4.4 Parexel Revenue in Pharmacovigilance Services Business (2018-2023)

11.4.5 Parexel Recent Development

11.5 Accenture

11.5.1 Accenture Company Detail

11.5.2 Accenture Business Overview

11.5.3 Accenture Pharmacovigilance Services Introduction

11.5.4 Accenture Revenue in Pharmacovigilance Services Business (2018-2023)

11.5.5 Accenture Recent Development

11.6 SOTERIUS

11.6.1 SOTERIUS Company Detail

11.6.2 SOTERIUS Business Overview

11.6.3 SOTERIUS Pharmacovigilance Services Introduction

11.6.4 SOTERIUS Revenue in Pharmacovigilance Services Business (2018-2023)

11.6.5 SOTERIUS Recent Development

11.7 SGS

11.7.1 SGS Company Detail

11.7.2 SGS Business Overview

11.7.3 SGS Pharmacovigilance Services Introduction

11.7.4 SGS Revenue in Pharmacovigilance Services Business (2018-2023)

11.7.5 SGS Recent Development

11.8 Medpace

11.8.1 Medpace Company Detail

11.8.2 Medpace Business Overview

11.8.3 Medpace Pharmacovigilance Services Introduction

11.8.4 Medpace Revenue in Pharmacovigilance Services Business (2018-2023)

11.8.5 Medpace Recent Development

11.9 PPD

11.9.1 PPD Company Detail

11.9.2 PPD Business Overview

11.9.3 PPD Pharmacovigilance Services Introduction

11.9.4 PPD Revenue in Pharmacovigilance Services Business (2018-2023)

11.9.5 PPD Recent Development

11.10 QVigilance

11.10.1 QVigilance Company Detail

11.10.2 QVigilance Business Overview

11.10.3 QVigilance Pharmacovigilance Services Introduction

11.10.4 QVigilance Revenue in Pharmacovigilance Services Business (2018-2023)

11.10.5 QVigilance Recent Development

11.11 Freyr Solutions

11.11.1 Freyr Solutions Company Detail

11.11.2 Freyr Solutions Business Overview

11.11.3 Freyr Solutions Pharmacovigilance Services Introduction

11.11.4 Freyr Solutions Revenue in Pharmacovigilance Services Business (2018-2023)

11.11.5 Freyr Solutions Recent Development

11.12 Navitas Life Sciences

11.12.1 Navitas Life Sciences Company Detail

11.12.2 Navitas Life Sciences Business Overview

11.12.3 Navitas Life Sciences Pharmacovigilance Services Introduction

11.12.4 Navitas Life Sciences Revenue in Pharmacovigilance Services Business (2018-2023)

11.12.5 Navitas Life Sciences Recent Development

11.13 MMS Holdings

11.13.1 MMS Holdings Company Detail

11.13.2 MMS Holdings Business Overview

11.13.3 MMS Holdings Pharmacovigilance Services Introduction

11.13.4 MMS Holdings Revenue in Pharmacovigilance Services Business (2018-2023)

11.13.5 MMS Holdings Recent Development

11.14 Amarex

11.14.1 Amarex Company Detail

11.14.2 Amarex Business Overview

11.14.3 Amarex Pharmacovigilance Services Introduction

11.14.4 Amarex Revenue in Pharmacovigilance Services Business (2018-2023)

11.14.5 Amarex Recent Development

11.15 Astrix Technology Group

11.15.1 Astrix Technology Group Company Detail

11.15.2 Astrix Technology Group Business Overview

11.15.3 Astrix Technology Group Pharmacovigilance Services Introduction

11.15.4 Astrix Technology Group Revenue in Pharmacovigilance Services Business (2018-2023)

11.15.5 Astrix Technology Group Recent Development

11.16 Cambridge Regulatory Services

11.16.1 Cambridge Regulatory Services Company Detail

11.16.2 Cambridge Regulatory Services Business Overview

11.16.3 Cambridge Regulatory Services Pharmacovigilance Services Introduction

11.16.4 Cambridge Regulatory Services Revenue in Pharmacovigilance Services Business (2018-2023)

11.16.5 Cambridge Regulatory Services Recent Development

11.17 CROMSOURCE

11.17.1 CROMSOURCE Company Detail

11.17.2 CROMSOURCE Business Overview

11.17.3 CROMSOURCE Pharmacovigilance Services Introduction

11.17.4 CROMSOURCE Revenue in Pharmacovigilance Services Business (2018-2023)

11.17.5 CROMSOURCE Recent Development

11.18 APCER Life Sciences

11.18.1 APCER Life Sciences Company Detail

11.18.2 APCER Life Sciences Business Overview

11.18.3 APCER Life Sciences Pharmacovigilance Services Introduction

11.18.4 APCER Life Sciences Revenue in Pharmacovigilance Services Business (2018-2023)

11.18.5 APCER Life Sciences Recent Development

11.19 Pharmya

11.19.1 Pharmya Company Detail

11.19.2 Pharmya Business Overview

11.19.3 Pharmya Pharmacovigilance Services Introduction

11.19.4 Pharmya Revenue in Pharmacovigilance Services Business (2018-2023)

11.19.5 Pharmya Recent Development

11.20 A+Science

11.20.1 A+Science Company Detail

11.20.2 A+Science Business Overview

11.20.3 A+Science Pharmacovigilance Services Introduction

11.20.4 A+Science Revenue in Pharmacovigilance Services Business (2018-2023)

11.20.5 A+Science Recent Development

11.21 Midas Pharma

11.21.1 Midas Pharma Company Detail

11.21.2 Midas Pharma Business Overview

11.21.3 Midas Pharma Pharmacovigilance Services Introduction

11.21.4 Midas Pharma Revenue in Pharmacovigilance Services Business (2018-2023)

11.21.5 Midas Pharma Recent Development

11.22 George Clinical

11.22.1 George Clinical Company Detail

11.22.2 George Clinical Business Overview

11.22.3 George Clinical Pharmacovigilance Services Introduction

11.22.4 George Clinical Revenue in Pharmacovigilance Services Business (2018-2023)

11.22.5 George Clinical Recent Development

11.23 Syneos Health

11.23.1 Syneos Health Company Detail

11.23.2 Syneos Health Business Overview

11.23.3 Syneos Health Pharmacovigilance Services Introduction

11.23.4 Syneos Health Revenue in Pharmacovigilance Services Business (2018-2023)

11.23.5 Syneos Health Recent Development

11.24 INPHARMATIS

11.24.1 INPHARMATIS Company Detail

11.24.2 INPHARMATIS Business Overview

11.24.3 INPHARMATIS Pharmacovigilance Services Introduction

11.24.4 INPHARMATIS Revenue in Pharmacovigilance Services Business (2018-2023)

11.24.5 INPHARMATIS Recent Development

11.25 Taimei Technology

11.25.1 Taimei Technology Company Detail

11.25.2 Taimei Technology Business Overview

11.25.3 Taimei Technology Pharmacovigilance Services Introduction

11.25.4 Taimei Technology Revenue in Pharmacovigilance Services Business (2018-2023)

11.25.5 Taimei Technology Recent Development

11.26 Extedo

11.26.1 Extedo Company Detail

11.26.2 Extedo Business Overview

11.26.3 Extedo Pharmacovigilance Services Introduction

11.26.4 Extedo Revenue in Pharmacovigilance Services Business (2018-2023)

11.26.5 Extedo Recent Development

11.27 WCG Clinical

11.27.1 WCG Clinical Company Detail

11.27.2 WCG Clinical Business Overview

11.27.3 WCG Clinical Pharmacovigilance Services Introduction

11.27.4 WCG Clinical Revenue in Pharmacovigilance Services Business (2018-2023)

11.27.5 WCG Clinical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pharmacovigilance Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Adverse Event Case Management

    Table 3. Key Players of Aggregate Reporting

    Table 4. Key Players of Signal Intelligence

    Table 5. Key Players of Risk Management

    Table 6. Global Pharmacovigilance Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Pharmacovigilance Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Pharmacovigilance Services Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Pharmacovigilance Services Market Share by Region (2018-2023)

    Table 10. Global Pharmacovigilance Services Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Pharmacovigilance Services Market Share by Region (2024-2029)

    Table 12. Pharmacovigilance Services Market Trends

    Table 13. Pharmacovigilance Services Market Drivers

    Table 14. Pharmacovigilance Services Market Challenges

    Table 15. Pharmacovigilance Services Market Restraints

    Table 16. Global Pharmacovigilance Services Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Pharmacovigilance Services Market Share by Players (2018-2023)

    Table 18. Global Top Pharmacovigilance Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Services as of 2022)

    Table 19. Ranking of Global Top Pharmacovigilance Services Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Pharmacovigilance Services Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Pharmacovigilance Services Product Solution and Service

    Table 23. Date of Enter into Pharmacovigilance Services Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Pharmacovigilance Services Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Pharmacovigilance Services Revenue Market Share by Type (2018-2023)

    Table 27. Global Pharmacovigilance Services Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Pharmacovigilance Services Revenue Market Share by Type (2024-2029)

    Table 29. Global Pharmacovigilance Services Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Pharmacovigilance Services Revenue Market Share by Application (2018-2023)

    Table 31. Global Pharmacovigilance Services Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Pharmacovigilance Services Revenue Market Share by Application (2024-2029)

    Table 33. North America Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Pharmacovigilance Services Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Pharmacovigilance Services Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Pharmacovigilance Services Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Pharmacovigilance Services Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Pharmacovigilance Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Pharmacovigilance Services Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Pharmacovigilance Services Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Pharmacovigilance Services Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Pharmacovigilance Services Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Pharmacovigilance Services Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Pharmacovigilance Services Market Size by Country (2024-2029) & (US$ Million)

    Table 48. PrimeVigilance Company Detail

    Table 49. PrimeVigilance Business Overview

    Table 50. PrimeVigilance Pharmacovigilance Services Product

    Table 51. PrimeVigilance Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 52. PrimeVigilance Recent Development

    Table 53. Quanticate Company Detail

    Table 54. Quanticate Business Overview

    Table 55. Quanticate Pharmacovigilance Services Product

    Table 56. Quanticate Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 57. Quanticate Recent Development

    Table 58. ProPharma Company Detail

    Table 59. ProPharma Business Overview

    Table 60. ProPharma Pharmacovigilance Services Product

    Table 61. ProPharma Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 62. ProPharma Recent Development

    Table 63. Parexel Company Detail

    Table 64. Parexel Business Overview

    Table 65. Parexel Pharmacovigilance Services Product

    Table 66. Parexel Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 67. Parexel Recent Development

    Table 68. Accenture Company Detail

    Table 69. Accenture Business Overview

    Table 70. Accenture Pharmacovigilance Services Product

    Table 71. Accenture Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 72. Accenture Recent Development

    Table 73. SOTERIUS Company Detail

    Table 74. SOTERIUS Business Overview

    Table 75. SOTERIUS Pharmacovigilance Services Product

    Table 76. SOTERIUS Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 77. SOTERIUS Recent Development

    Table 78. SGS Company Detail

    Table 79. SGS Business Overview

    Table 80. SGS Pharmacovigilance Services Product

    Table 81. SGS Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 82. SGS Recent Development

    Table 83. Medpace Company Detail

    Table 84. Medpace Business Overview

    Table 85. Medpace Pharmacovigilance Services Product

    Table 86. Medpace Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 87. Medpace Recent Development

    Table 88. PPD Company Detail

    Table 89. PPD Business Overview

    Table 90. PPD Pharmacovigilance Services Product

    Table 91. PPD Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 92. PPD Recent Development

    Table 93. QVigilance Company Detail

    Table 94. QVigilance Business Overview

    Table 95. QVigilance Pharmacovigilance Services Product

    Table 96. QVigilance Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 97. QVigilance Recent Development

    Table 98. Freyr Solutions Company Detail

    Table 99. Freyr Solutions Business Overview

    Table 100. Freyr Solutions Pharmacovigilance Services Product

    Table 101. Freyr Solutions Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 102. Freyr Solutions Recent Development

    Table 103. Navitas Life Sciences Company Detail

    Table 104. Navitas Life Sciences Business Overview

    Table 105. Navitas Life Sciences Pharmacovigilance Services Product

    Table 106. Navitas Life Sciences Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 107. Navitas Life Sciences Recent Development

    Table 108. MMS Holdings Company Detail

    Table 109. MMS Holdings Business Overview

    Table 110. MMS Holdings Pharmacovigilance Services Product

    Table 111. MMS Holdings Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 112. MMS Holdings Recent Development

    Table 113. Amarex Company Detail

    Table 114. Amarex Business Overview

    Table 115. Amarex Pharmacovigilance Services Product

    Table 116. Amarex Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 117. Amarex Recent Development

    Table 118. Astrix Technology Group Company Detail

    Table 119. Astrix Technology Group Business Overview

    Table 120. Astrix Technology Group Pharmacovigilance Services Product

    Table 121. Astrix Technology Group Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 122. Astrix Technology Group Recent Development

    Table 123. Cambridge Regulatory Services Company Detail

    Table 124. Cambridge Regulatory Services Business Overview

    Table 125. Cambridge Regulatory Services Pharmacovigilance Services Product

    Table 126. Cambridge Regulatory Services Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 127. Cambridge Regulatory Services Recent Development

    Table 128. CROMSOURCE Company Detail

    Table 129. CROMSOURCE Business Overview

    Table 130. CROMSOURCE Pharmacovigilance Services Product

    Table 131. CROMSOURCE Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 132. CROMSOURCE Recent Development

    Table 133. APCER Life Sciences Company Detail

    Table 134. APCER Life Sciences Business Overview

    Table 135. APCER Life Sciences Pharmacovigilance Services Product

    Table 136. APCER Life Sciences Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 137. APCER Life Sciences Recent Development

    Table 138. Pharmya Company Detail

    Table 139. Pharmya Business Overview

    Table 140. Pharmya Pharmacovigilance Services Product

    Table 141. Pharmya Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 142. Pharmya Recent Development

    Table 143. A+Science Company Detail

    Table 144. A+Science Business Overview

    Table 145. A+Science Pharmacovigilance Services Product

    Table 146. A+Science Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 147. A+Science Recent Development

    Table 148. Midas Pharma Company Detail

    Table 149. Midas Pharma Business Overview

    Table 150. Midas Pharma Pharmacovigilance Services Product

    Table 151. Midas Pharma Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 152. Midas Pharma Recent Development

    Table 153. George Clinical Company Detail

    Table 154. George Clinical Business Overview

    Table 155. George Clinical Pharmacovigilance Services Product

    Table 156. George Clinical Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 157. George Clinical Recent Development

    Table 158. Syneos Health Company Detail

    Table 159. Syneos Health Business Overview

    Table 160. Syneos Health Pharmacovigilance Services Product

    Table 161. Syneos Health Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 162. Syneos Health Recent Development

    Table 163. INPHARMATIS Company Detail

    Table 164. INPHARMATIS Business Overview

    Table 165. INPHARMATIS Pharmacovigilance Services Product

    Table 166. INPHARMATIS Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 167. INPHARMATIS Recent Development

    Table 168. Taimei Technology Company Detail

    Table 169. Taimei Technology Business Overview

    Table 170. Taimei Technology Pharmacovigilance Services Product

    Table 171. Taimei Technology Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 172. Taimei Technology Recent Development

    Table 173. Extedo Company Detail

    Table 174. Extedo Business Overview

    Table 175. Extedo Pharmacovigilance Services Product

    Table 176. Extedo Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 177. Extedo Recent Development

    Table 178. WCG Clinical Company Detail

    Table 179. WCG Clinical Business Overview

    Table 180. WCG Clinical Pharmacovigilance Services Product

    Table 181. WCG Clinical Revenue in Pharmacovigilance Services Business (2018-2023) & (US$ Million)

    Table 182. WCG Clinical Recent Development

    Table 183. Research Programs/Design for This Report

    Table 184. Key Data Information from Secondary Sources

    Table 185. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pharmacovigilance Services Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Pharmacovigilance Services Market Share by Type: 2022 VS 2029

    Figure 3. Adverse Event Case Management Features

    Figure 4. Aggregate Reporting Features

    Figure 5. Signal Intelligence Features

    Figure 6. Risk Management Features

    Figure 7. Global Pharmacovigilance Services Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Pharmacovigilance Services Market Share by Application: 2022 VS 2029

    Figure 9. Biotechnology and Pharmaceuticals Case Studies

    Figure 10. Contract Research Organization Case Studies

    Figure 11. Hospital Case Studies

    Figure 12. KPO / BPO Case Studies

    Figure 13. Healthcare Institutions Case Studies

    Figure 14. Others Case Studies

    Figure 15. Pharmacovigilance Services Report Years Considered

    Figure 16. Global Pharmacovigilance Services Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Pharmacovigilance Services Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Pharmacovigilance Services Market Share by Region: 2022 VS 2029

    Figure 19. Global Pharmacovigilance Services Market Share by Players in 2022

    Figure 20. Global Top Pharmacovigilance Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Services as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Pharmacovigilance Services Revenue in 2022

    Figure 22. North America Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Pharmacovigilance Services Market Share by Country (2018-2029)

    Figure 24. United States Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Pharmacovigilance Services Market Share by Country (2018-2029)

    Figure 28. Germany Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Pharmacovigilance Services Market Share by Region (2018-2029)

    Figure 36. China Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Pharmacovigilance Services Market Share by Country (2018-2029)

    Figure 44. Mexico Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Pharmacovigilance Services Market Share by Country (2018-2029)

    Figure 48. Turkey Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Pharmacovigilance Services Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. PrimeVigilance Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 51. Quanticate Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 52. ProPharma Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 53. Parexel Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 54. Accenture Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 55. SOTERIUS Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 56. SGS Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 57. Medpace Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 58. PPD Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 59. QVigilance Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 60. Freyr Solutions Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 61. Navitas Life Sciences Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 62. MMS Holdings Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 63. Amarex Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 64. Astrix Technology Group Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 65. Cambridge Regulatory Services Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 66. CROMSOURCE Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 67. APCER Life Sciences Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 68. Pharmya Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 69. A+Science Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 70. Midas Pharma Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 71. George Clinical Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 72. Syneos Health Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 73. INPHARMATIS Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 74. Taimei Technology Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 75. Extedo Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 76. WCG Clinical Revenue Growth Rate in Pharmacovigilance Services Business (2018-2023)

    Figure 77. Bottom-up and Top-down Approaches for This Report

    Figure 78. Data Triangulation

    Figure 79. Key Executives Interviewed